Literature DB >> 10459338

Karyotype studies in 18 ependymomas with literature review of 107 cases.

C Mazewski1, S Soukup, E Ballard, B Gotwals, B Lampkin.   

Abstract

Cytogenetic studies from 17 pediatric ependymomas and 1 ependymoblastoma are presented. Eight tumors had abnormal karyotypes. Another 107 published cases of cytogenetic analyses from pediatric and adult ependymomas or ependymoblastomas were reviewed. Of the total 125 tumors, 83 (66%) had abnormal karyotypes, of which 24 had a sole autosomal abnormality. Approximately one third had monosomy 22 (-22) or breakpoint 22q11-13, with a higher incidence in adult (56%) versus pediatric (28%) tumors. Structural abnormalities of chromosomes 1, 6, and 17, and numerical abnormalities of 7, 9, 12, and 20, in particular, are also discussed. Although no primary cytogenetic abnormality is evident, these findings may provide direction for additional investigations regarding the classification of these tumors.

Entities:  

Mesh:

Year:  1999        PMID: 10459338     DOI: 10.1016/s0165-4608(99)00046-1

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  17 in total

1.  A deletion causing NF2 exon 9 skipping is associated with familial autosomal dominant intramedullary ependymoma.

Authors:  Ilyess Zemmoura; Patrick Vourc'h; Agathe Paubel; Béatrice Parfait; Joëlle Cohen; Frédéric Bilan; Alain Kitzis; Cécilia Rousselot; Fabrice Parker; Patrick François; Christian R Andres
Journal:  Neuro Oncol       Date:  2013-12-18       Impact factor: 12.300

Review 2.  Understanding Ependymoma Oncogenesis: an Update on Recent Molecular Advances and Current Perspectives.

Authors:  Kirti Gupta; Pravin Salunke
Journal:  Mol Neurobiol       Date:  2015-12-28       Impact factor: 5.590

3.  Evaluation of chromosome 1q gain in intracranial ependymomas.

Authors:  Madhu Rajeshwari; Mehar Chand Sharma; Aanchal Kakkar; Aruna Nambirajan; Vaishali Suri; Chitra Sarkar; Manmohan Singh; Ravindra Kumar Saran; Rakesh Kumar Gupta
Journal:  J Neurooncol       Date:  2016-01-02       Impact factor: 4.130

Review 4.  Ependymoma in children: molecular considerations and therapeutic insights.

Authors:  J-H Kim; Y Huang; A S Griffin; P Rajappa; J P Greenfield
Journal:  Clin Transl Oncol       Date:  2013-04-25       Impact factor: 3.405

Review 5.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

Review 6.  The genetic and epigenetic basis of ependymoma.

Authors:  Stephen C Mack; Michael D Taylor
Journal:  Childs Nerv Syst       Date:  2009-06-18       Impact factor: 1.475

7.  Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.

Authors:  Andrey Korshunov; Kai Neben; Gunnar Wrobel; Bjoern Tews; Axel Benner; Meinhard Hahn; Andrey Golanov; Peter Lichter
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

8.  Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.

Authors:  Audrey Rousseau; Ahmed Idbaih; François Ducray; Emmanuelle Crinière; Michèle Fèvre-Montange; Anne Jouvet; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2009-10-29       Impact factor: 4.130

Review 9.  Ependymoma.

Authors:  Charles Teo; Peter Nakaji; Patricia Symons; Vivienne Tobias; Richard Cohn; Robert Smee
Journal:  Childs Nerv Syst       Date:  2003-05-22       Impact factor: 1.475

10.  Immunohistochemical markers for prognosis of ependymal neoplasms.

Authors:  Andrey Korshunov; Andrey Golanov; Valery Timirgaz
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.